Latest market price
38.23
+0.61+1.62%
OverviewShort InterestFilings
XENEQT13Xenon Pharmaceuticals Inc.·NASDAQ
38.23+1.62%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 16, 20264Statement of changes in beneficial ownership
Oct 01, 20264Statement of changes in beneficial ownership
Oct 01, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 31, 20264Statement of changes in beneficial ownership
Aug 28, 2026144Notice of proposed sale of restricted securities
Aug 13, 2026144Notice of proposed sale of restricted securities
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 05, 2026144Notice of proposed sale of restricted securities
Jun 05, 2026144Notice of proposed sale of restricted securities
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 2026S-8Registration of employee benefit securities
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 20268-KCurrent report
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 2026S-8 POSS-8 POS
#1 / 25 of 311
Page
▼
/ 13